1.
Human stem cells help mice in MS research
File Format: PDF/Adobe Acrobat - View as HTML Human stem cells help mice in MS research. Sep. 7, 2008. Judy Siegel-Itzkovich , THE JERUSALEM POST. Human embryonic stem cells injected by Hadassah ...
2.
Page 1 Contacts: Dr. Solveigh Mähler Director Investor Relations ...
File Format: PDF/Adobe Acrobat - View as HTML Dec 3, 2007 ... Sheo S. Rai. Head, Communications. Tel: +65-6395 7784. Email: sheo_shanker_rai@edb.gov.sg www.bio1capital.com. QIAGEN and Bio*One Capital ...
3.
FOR IMMEDIATE RELEASE S*BIO Receives BioSpectrum Editor's Choice ...
File Format: PDF/Adobe Acrobat - View as HTML Mar 6, 2009 ... and leading position in Singapore’s biotechnology industry. “We are proud to be named Singapore’s emerging bioscience company of the year,” ...
4.
FOR IMMEDIATE RELEASE S*BIO Initiates U.S. Phase I Clinical Trials ...
File Format: PDF/Adobe Acrobat - View as HTML Singapore, Sept. 18, 2008 - S*BIO Pte Ltd today announced the initiation of multi-center Phase I clinical trials of SB1518, a potent and orally-active JAK2 ...
5.
Page 1 Codexis, Inc. 200 Penobscot Drive Redwood City, CA 94063 ...
File Format: PDF/Adobe Acrobat - View as HTML CODEXIS APPOINTS SINGAPORE LABORATORIES. MANAGING DIRECTOR. Redwood City, CA – Aug 21, 2007 -- Codexis, Inc., a private biotechnology ...
6.
Bio*One Capital
S*BIO Receives BioSingapore’s 2009 Award for the Most Successful ... S*BIO Receives BioSpectrum Editor's Choic, Emerging BioScience Company of Singapore ...
7.
Bio*One Capital
FORMA Therapeutics and Experimental Therapeutics Centre of Singapore Collaborate to Develop Therapeutics Against a Broad Range of Novel Targets ...
8.
Bio*One Capital
FORMA Therapeutics and Experimental Therapeutics Centre of Singapore Collaborate to Develop Therapeutics Against a Broad Range of Novel Targets ...
9.
S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the ...
File Format: PDF/Adobe Acrobat - View as HTML Jan 6, 2009 ... develop and commercialize S*BIO’s novel JAK2 inhibitors, SB1518 and SB1578. Under the terms of the agreement, S*BIO is eligible to receive ...
10.
Patents Issue for Inotek Pharmaceuticals’ Lead Clinical Candidates ...
File Format: PDF/Adobe Acrobat - View as HTML Nov 13, 2008 ... Inotek Pharmaceuticals Corporation announced today that the United States Patent and. Trademark Office has issued two new patents covering ...